Cancer multi-omics faces challenges in handling the scale, complexity, and heterogeneity of multi-omics data, limiting progress in variant interpretation, tumor classification, and modeling cancer evolution. Quantum computing offers a new paradigm using superposition, entanglement, and quantum interference to efficiently explore vast solution spaces. This Perspective highlights how quantum algorithms-such as Quantum Support Vector Machines, Quantum Principal Component Analysis, and quantum generative models-could enhance key tasks in precision oncology, including multi-omics integration, spatial transcriptomics, and neoantigen prediction. Current technical barriers, like qubit noise and limited quantum memory, are discussed alongside strategies to connect quantum computing with biomedical research. Interdisciplinary collaboration will be essential to realizing quantum advantage in cancer multi-omics.
Cancer multi-omics faces challenges in handling the scale, complexity, and heterogeneity of multi-omics data, limiting progress in variant interpretation, tumor classification, and modeling cancer evolution. Quantum computing offers a new paradigm using superposition, entanglement, and quantum interference to efficiently explore vast solution spaces. This Perspective highlights how quantum algorithms-such as Quantum Support Vector Machines, Quantum Principal Component Analysis, and quantum generative models-could enhance key tasks in precision oncology, including multi-omics integration, spatial transcriptomics, and neoantigen prediction. Current technical barriers, like qubit noise and limited quantum memory, are discussed alongside strategies to connect quantum computing with biomedical research. Interdisciplinary collaboration will be essential to realizing quantum advantage in cancer multi-omics.
Cancer remains a major global health challenge, necessitating the development of accurate, scalable, and clinically reliable diagnostic approaches. Artificial intelligence (AI) has significantly enhanced cancer detection through advanced analysis of medical imaging, histopathology, and multi-omics data. However, conventional AI models face limitations related to computational scalability, optimization complexity, and data heterogeneity. Quantum computing introduces a fundamentally different computational paradigm based on superposition, entanglement, and probabilistic state evolution. The integration of quantum computing with machine learning referred to as Quantum Artificial Intelligence (QAI) has emerged as a promising approach to address these challenges. This review critically evaluates the role of QAI in cancer detection through a systematic analysis of literature published between 2015 and 2026. The findings suggest that QAI can enhance feature representation, accelerate optimization processes, and improve predictive performance. Hybrid quantum-classical models show potential in tumor classification, multi-omics integration, and real-time clinical decision-making. Despite these advances, significant challenges remain, including hardware limitations, lack of large-scale validation, and ethical concerns. Overall, QAI represents a promising yet emerging paradigm with potential to transform early cancer detection and precision oncology. This review uniquely synthesizes quantum-AI approaches in oncology, emphasizing hybrid quantum-classical models as the most practical translational pathway for clinical adoption.
Precision medicine aims to tailor healthcare by integrating individual genetic, epigenetic, transcriptomic, proteomic, and clinical data, collectively referred to as multi-omic data. However, the scale and complexity of such multi-omics datasets challenge classical computing approaches. Quantum computing, which leverages superposition and entanglement (quantum-level correlations between particles), offers a fundamentally new paradigm for accelerating molecular simulations, biomarker discovery, and high-dimensional data analysis. This review explores the convergence of quantum computing and it's potential to provide unmet needs in precision biomedicine research, with emphasis on applications in diagnostic modeling, multi-omic data integration and drug discovery. We highlight early proof-of-concept studies demonstrating the use of quantum machine learning for disease prediction, quantum algorithms for protein folding, and quantum generative models for novel drug design. Hybrid quantum-classical workflows are also already enabling gene network inference and prioritization of variants of uncertain significance, the latter of which is a major focus of multi-omic research worldwide. Emerging directions include digital twin simulations and real-time clinical decision support powered by quantum models. Looking ahead, the long-term vision for quantum computing in biomedicine involves in silico modeling of entire biological systems to simulate cellular responses to perturbations like drug treatments, enabling clinicians to test therapies in virtual patients before real-world application. Despite these advances, practical implementation remains limited by hardware constraints, qubit decoherence, algorithm scalability, and regulatory barriers. Nonetheless, as quantum hardware evolves and AI-aligned quantum algorithms mature, their integration holds transformative potential. Quantum computing may eventually shorten diagnostic timelines, improve therapeutic precision, and make biomedical innovation more globally accessible. We outline a roadmap for translating these technologies into next-generation precision medicine.
Multi-omics integration has become a cornerstone of personalized medicine, enabling researchers to connect genomic, transcriptomic, proteomic, metabolomic, and epigenomic data to reveal complex biological mechanisms and individualized disease signatures. However, the extreme dimensionality, heterogeneity, and nonlinear interactions across omics layers challenge even the most advanced classical machine learning methods. Quantum Machine Learning (QML) offers a powerful alternative by exploiting quantum superposition, entanglement, and high-dimensional feature embeddings to model multi-omics interactions more efficiently. This study proposes a hybrid quantum–classical framework that combines quantum kernel estimation, variational quantum classifiers, and quantum-enhanced feature fusion networks to generate integrative biological signatures for precision diagnostics. Simulation results using benchmark multi-omics datasets demonstrate improved classification accuracy, enhanced sensitivity to weak biological signals, and reduced computational overhead compared to classical baselines. These findings highlight the potential of QML to accelerate multi-omics insights and pave the way toward truly personalized, predictive healthcare.
Quantum machine learning (QML) presents novel opportunities for resolving, accelerating, and refining computational biology challenges. In biomedical research and personalized medicine, multi-omics integration offers a comprehensive understanding of complex biological systems, bridging the gap between basic research and clinical applications. Recent advancements in quantum computing could enhance multi-omics integration by leveraging unique quantum principles, potentially revealing intricate patterns in multi-omics datasets and offering new insights into the molecular landscape of lung cancer. This study focuses on the integration, feature selection, diagnostic classification, and biomarker identification of lung cancer types-LUAD primary tumor and solid tissue normal-using QML. Given the heterogeneity and high dimensionality of the data, we aim to assess the performance of QML in feature selection, reduction, encoding, and diagnostic classification in integrated multi-omics cancer datasets. We demonstrate the efficacy of Quantum Neural Networks (QNNs) for classifying multi-omics lung cancer data from The Cancer Genome Atlas, comparing our framework with 16 and 64 dimensions of feature using QML. Our results show that the Multi-omic Quantum Machine Learning (MQML) framework achieves superior classification performance with smaller training datasets, as determined by significant and non-significant p-values. This study provides empirical evidence for the potential application of unconventional computing approaches in biomed-ical sciences, particularly in oncology research, including cancer subtype diagnostic, survival, and stage classification. Key results include the identification of sixteen genes and thirty-two genes with the hybrid quantum-classical neural net-work model, with notable genes such as MIR632, CYP19A1, RP11-108K3.1, C14orf39, THUMPD1, ACSM3, GSC, MIR92a-2, DYRK1B, DNAJA1, IRX1, FMR1, POU2F2, MIR9-2, ZNF274, MIR196a-1, MIR3653, MIR33b, MIR301a, MIR182, MIR520a, PYGO2, EMX2OS, EMX2, RP11-550F7.1, RPS11, MIR20a, EIF4G2, IGLV1-47, RP11-180M15.7, SCYL3, AC107081.5, C2orf47, FST, MIR7-1, SLC22A18, CLDN5, and AC007879.7 identified as having significant and non-significant p-values asso-ciated with LUAD patient predictions.
Integrating the various omics to conduct a thorough research of biological systems is known as multi-omics. It enables a comprehensive comprehension of the intricate relationships and dynamics that exist within an organism. Understanding complicated biological systems and developing bioengineering applications like disease modelling, metabolism engineering, & precision medicine depend on integrating of multi-omics data. However, traditional computational methods are severely hampered by the high complexity, heterogeneity, & nonlinear interactions among genomes, genomics, proteomics, and metabolomics data. In order to effectively describe intricate cross-omics interactions, this research proposes a quantum computing-based framework for multiple-omics data integration that makes use of the concepts of quantum juxtaposition and entanglement. A hybrid cognitive–classical architecture is suggested, wherein classical optimisation methods are used for training and multi-omics features are converted into states of matter and processed utilising variational quantum circuits. Phenotype prediction and route analysis are two downstream bioengineering tasks that make use of the integrated quantum representations. In comparison to classical approaches, the suggested strategy delivers better integration efficiency and prediction performance, as demonstrated by experimental assessments utilising simulated quantum settings. The findings demonstrate quantum computing's promise as a potent instrument for precise and scalable multi-omics data integration, opening the door for applications in systems biology and bioengineering of the future.
Integrating the various omics to conduct a thorough research of biological systems is known as multi-omics. It enables a comprehensive comprehension of the intricate relationships and dynamics that exist within an organism. Understanding complicated biological systems and developing bioengineering applications like disease modelling, metabolism engineering, & precision medicine depend on integrating of multi-omics data. However, traditional computational methods are severely hampered by the high complexity, heterogeneity, & nonlinear interactions among genomes, genomics, proteomics, and metabolomics data. In order to effectively describe intricate cross-omics interactions, this research proposes a quantum computing-based framework for multiple-omics data integration that makes use of the concepts of quantum juxtaposition and entanglement. A hybrid cognitive–classical architecture is suggested, wherein classical optimisation methods are used for training and multi-omics features are converted into states of matter and processed utilising variational quantum circuits. Phenotype prediction and route analysis are two downstream bioengineering tasks that make use of the integrated quantum representations. In comparison to classical approaches, the suggested strategy delivers better integration efficiency and prediction performance, as demonstrated by experimental assessments utilising simulated quantum settings. The findings demonstrate quantum computing's promise as a potent instrument for precise and scalable multi-omics data integration, opening the door for applications in systems biology and bioengineering of the future.